These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10937975)

  • 1. Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1.
    Petrie MC; McClure SJ; Love MP; McMurray JJ
    Eur J Heart Fail; 1999 Mar; 1(1):25-9. PubMed ID: 10937975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What do vasoactive peptides tell about the heart?].
    Uusimaa P
    Duodecim; 1998; 22(114):2281, 2283-4. PubMed ID: 11757087
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure.
    Hillier C; Petrie MC; Love MP; Johnston F; MacLean MR; McMurray JJ
    Clin Sci (Lond); 2001 Jul; 101(1):45-51. PubMed ID: 11410113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of adrenomedullin in patients with heart failure.
    Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
    J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal brain natriuretic peptide is a more powerful predictor of mortality than endothelin-1, adrenomedullin and tumour necrosis factor-alpha in patients referred for consideration of cardiac transplantation.
    Gardner RS; Chong V; Morton I; McDonagh TA
    Eur J Heart Fail; 2005 Mar; 7(2):253-60. PubMed ID: 15701475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent trends in studies of the etiology of hypertension: New endocrine regulators of blood pressure].
    Kita T; Eto T
    Nihon Rinsho; 2001 May; 59(5):886-91. PubMed ID: 11391987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac natriuretic peptides in heart failure].
    Cvorisćec D; Cepelak I
    Lijec Vjesn; 2006; 128(9-10):279-85. PubMed ID: 17128666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurohumoral mechanisms in pathophysiology of chronic heart failure].
    Rubin W; Kosmala W; Kobusiak-Prokopowicz M
    Przegl Lek; 2000; 57(12):750-6. PubMed ID: 11398602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
    Kalra PR; Anker SD; Coats AJ
    Cardiovasc Res; 2001 Aug; 51(3):495-509. PubMed ID: 11476740
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuated natriuretic response to adrenomedullin in experimental heart failure.
    Jougasaki M; Heublein DM; Sandberg SM; Burnett JC
    J Card Fail; 2001 Mar; 7(1):75-83. PubMed ID: 11264553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological strategies for the treatment of heart failure.
    Chin BS; Lip GY
    Curr Opin Investig Drugs; 2001 Jul; 2(7):923-8. PubMed ID: 11757792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving risk stratification in heart failure: a role for new biomarkers?
    Yandle TG; Troughton RW
    Eur J Heart Fail; 2010 Apr; 12(4):315-8. PubMed ID: 20335349
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.